Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients

May 2019

We're still getting questions about whether beta-blockers are safe for patients with COPD or asthma.

Many of us were taught to avoid beta-blockers in these patients...because of concerns about bronchoconstriction.

But cardioSELECTIVE options (metoprolol, bisoprolol, etc) don't cause more exacerbations or reduce airway function in COPD or asthma. And patients still respond to beta-agonists (albuterol, salmeterol, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Be Ready With Answers About Aspirin for CV Disease Prevention
Depression Save Spravato as a Last-Line Option for Resistant Depression
Antithrombotics Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Dermatology Prepare Patients for Actinic Keratosis Treatment
Parkinson's Disease Save Inbrija for "Off" Episodes of Parkinson's Despite Optimized Meds
Beta-Blockers Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients
Ophthalmology Lean Away From Cequa for Dry Eyes
Establish Boundaries for Prescribing Meds for Yourself or Family
Infectious Diseases Be Prepared to Manage Osteomyelitis Patients on Oral Antibiotics
ADHD Put Psychosis Risk for ADHD Stimulants in Perspective
Women's Health Expect Limited Use of IV Brexanolone (Zulresso) for Postpartum Depression

Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents